logo-loader
Frontier IP Group PLC

Frontier IP spins out third Portuguese firm Insignals Neurotech

Insignals is developing wearable wireless devices to precisely measure wrist rigidity to help surgeons place brain implants more accurately during surgery

Brain scans
Frontier said Insignals had already received interest from potential industry partners

Frontier IP Group Plc (LON:FIPP) has unveiled its third Portuguese spin out, Insignals Neurotech.

The IP commercialisation firm said it would hold a 33% stake in Insignals, which is a spin-out from the work of Professor João Paulo Cunha at the University of Porto and is developing wearable wireless devices to precisely measure wrist rigidity to help surgeons place brain implants more accurately during surgery on patients with Parkinson’s, epilepsy, and other neural conditions.

WATCH: Frontier IP spins out third Portuguese firm Insignals Neurotech

Wrist rigidity is used by doctors to decide the optimum position for an implant during surgery, but currently, this is done by two trained surgeons making a judgement by manually manipulating the wrist, meaning the procedure can be biased by the physicians' experience and perception.

Frontier said the device could help pharmaceutical companies monitor or assess the impact of new drugs in rigidity reduction during clinical trials, adding that Insignals had already received interest from potential industry partners and was looking to enter collaboration agreements to extend clinical trials in Portugal, the UK, and Germany.

Neil Crabb, Frontier’s chief executive, said that Insignals technology had “the potential to improve the accuracy of where to place an implant and relieve the symptoms of Parkinson's disease and other neural conditions”.

“The spin-out provides further evidence that we are now gaining serious traction in Portugal, a country with a lot of exciting IP and few companies providing commercialisation services."

João Paulo Cunha, co-founder of Insignals, added: "The creation of the Insignals Neurotech startup with our partners from Frontier IP will provide a strong innovation vehicle to consolidate the neuro-technology we've been developing for several years."

In early trading Tuesday, Frontier IP shares were up 0.6% at 87p.

--Adds share price--

Quick facts: Frontier IP Group PLC

Price: £0.67

Market: AIM
Market Cap: £28.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Frontier IP focused on further industrial engagement across portfolio

Neil Crabb, chief executive of Frontier IP Group Plc (LON:FIPP) caught up with Proactive's Andrew Scott following the release of their half-year report. Frontier’s portfolio includes AI drug researcher Exscientia which secured a €15mln strategic investment from drug discovery company...

on 29/3/18

2 min read